期刊文献+

Adenovirus-mediated HSV-TK Gene Therapy Using hTERT Promoter in CNE Cells in vitro

Adenovirus-mediated HSV-TK Gene Therapy Using hTERT Promoter in CNE Cells in vitro
下载PDF
导出
摘要 Human telomerase reverse transcriptase(hTERT) activity was detected in human nasopharyngeal carcinoma celI(CNE) but not in human normal lung fibroblas t(CCD-11Lu). Recombinant adenoviruses Ad-CMV-TK-enh and Ad-hTERT-TK-enh were constructed and infected into normal fibroblasts and nasopharyngeal carcinoma cells. Ad-CMV-TK-enh with 100 μmol/L of ganciclovir(GCV) caused 87% of CCD-11Lu cells death and 91% of CNE cells death, Ad-hTERT-TK-enh with 100 μmol/L of GCV caused 24% of CCD-11Lu cells death and 79% of CNE cells death. These results indicate that the Ad-hTERT-TK-enh with GCV may be a useful method in suppressing tumor growth in targeted nasopharyngeal carcinoma gene therapy. Human telomerase reverse transcriptase(hTERT) activity was detected in human nasopharyngeal carcinoma celI(CNE) but not in human normal lung fibroblas t(CCD-11Lu). Recombinant adenoviruses Ad-CMV-TK-enh and Ad-hTERT-TK-enh were constructed and infected into normal fibroblasts and nasopharyngeal carcinoma cells. Ad-CMV-TK-enh with 100 μmol/L of ganciclovir(GCV) caused 87% of CCD-11Lu cells death and 91% of CNE cells death, Ad-hTERT-TK-enh with 100 μmol/L of GCV caused 24% of CCD-11Lu cells death and 79% of CNE cells death. These results indicate that the Ad-hTERT-TK-enh with GCV may be a useful method in suppressing tumor growth in targeted nasopharyngeal carcinoma gene therapy.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2009年第1期60-63,共4页 高等学校化学研究(英文版)
基金 Supported in Part by the Agency of Science and Technology of Sichuan Province, China(No.2008JY0020) the National Natural Science Foundation of China(No.30872396).
关键词 HTERT HSV-TK ADENOVIRUS Nasopharyngeal carcinoma hTERT HSV-TK Adenovirus Nasopharyngeal carcinoma
  • 相关文献

参考文献15

  • 1Mathis J. M., Williams B. J., Sibley D. A., J. Gene. Med, 2006, 8, 1105.
  • 2Moolten F. L., Cancer Res., 1986, 46, 5276.
  • 3Adam V., Patterson M. E, Current Pharmaceutical Design, 2003, 9(26), 2131.
  • 4Greider C. W., Annu. Rev. Biochem, 1996, 65, 337.
  • 5Wright W. E., Shay J. W., Exp. Gerontol., 1992, 27(4), 383.
  • 6Greider C. W., Blackburn E. H., Cell, 1985, (2 Pt 1), 405.
  • 7Song Joon-seok, Kim Hyun-pyo, Yoon won-suck, Biosci. Biotechnol. Biochem., 2003, 67(11), 2344.
  • 8Yi Z. C., Wang H, Zhang G. Y., Oral Oncology, 2007, 43(9), 898/
  • 9Sung F. L., Hui E. E, Tao Q., Cancer Letters, 2007, 253(1), 74.
  • 10Kerekhanjanarong V., Sitawarin S., Sakdikul S., Otolaryngology-Head and Neck Surgery, 2000, 123(5), 624.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部